Due to the beneficial effect of adiponectin on several diseases related to obesity, including diabetes, cardiac fibrosis, and a range of cancers, the pharmacological elevation of circulating adiponectin became the main interest of multiple research groups. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.